[Clinical picture, course and therapeutic efficiency of pulmonary tuberculosis in patients with organochlorine pesticides and hepatitis B markers].
A total of 356 patients with active forms of pulmonary tuberculosis were examined. Toxicological and radioimmunological (RIA) studies revealed serum organochlorine pesticides (OCP) and virus hepatitis B markers (VBHM) in 225 (63.2%) and 219 (61.6%), respectively. Pulmonary tuberculosis was demonstrated to run worse in patients with OCP and VBHM who tolerated antibiotics worse, showed a high incidence of side effects, lower efficiency of treatment. Pathogenetic benzonal therapy with enterosorption in tuberculosis enhances therapeutical efficiency by 20-25% and reduces the incidence of side effects by 1.5-2 times.